Lornia Villalobos

Lornia Villalobos serves as a key procurement lead within the W40M MRC0 West agency under the Department of the Army, responsible for securing critical medical readiness capabilities essential to operational field care. She manages the acquisition of advanced in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management solutions that enable high-acuity medical support in austere environments. Her work directly supports the agency’s mission to ensure medical sovereignty by delivering reliable, deployable diagnostic and therapeutic technologies to military medical units worldwide. Villalobos specializes in complex, high-stakes procurements requiring strict regulatory compliance, including FDA-regulated medical devices and laboratory-grade reagents. She maintains consistent working relationships with leading suppliers including Roche Diagnostics Corporation, Cardinal Health 414, LLC, and Surgical Neuromonitoring Associates, Inc., partnering primarily with established industry leaders in diagnostic and surgical technology. Her contracting patterns reflect a preference for proven vendors with demonstrated capability in military-grade medical systems, often leveraging indefinite-delivery/indefinite-quantity (IDIQ) and blanket purchase agreements to ensure rapid response and supply chain resilience. While she collaborates with large primes, her portfolio also includes niche specialists in trauma care and surgical monitoring. Villalobos’ set-aside preferences are overwhelmingly aligned with open competition, with 92.3% of awards issued without socioeconomic set-asides. Only 7.7% of contracts are structured as total small business set-asides under FAR 19.5, indicating a procurement strategy prioritizing technical capability and mission-critical performance over socioeconomic preferences, though small business participation remains a secondary consideration when competitive bids meet technical thresholds. Her procurement focus is concentrated in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), accounting for over half of her portfolio, followed by surgical instrument manufacturing and medical laboratory services. She possesses deep technical expertise in diagnostic assay systems, sterile processing equipment, and point-of-care testing technologies essential to forward-deployed medical units.